Abby Fleming

Abby Fleming is the Global Commercial Strategy Director for Bladder Cancer at Johnson & Johnson, where they lead commercial operations and strategic initiatives. Previously, Abby held various roles at Janssen-Cilag and Johnson & Johnson, including Director of UK MedTech and Gynaecology Business Development Manager. They have excelled in marketing and business development, achieving awards for sales and innovative campaigns throughout their career. Abby's educational background includes a 1st Class Honours BA in Business and Psychology from The University of Glasgow and a CIM Professional Diploma in Marketing from the London School of Business and Finance.